Defined-Formula Diets versus Steroids in the Treatment of Active Crohn's Disease: A Meta-Analysis

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 3, 1996, Pages 267-272

  Messori, A ^a   Trallori, G ^a   D'Albasio, G ^a   Milla, M ^a   Vannozzi, G ^a   Pacini, F ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Crohn's disease; Diet; Meta analysis; Steroids

Indexed keywords

COLISTIN; CORTICOSTEROID; FRAMYCETIN; METHYLPREDNISOLONE; NYSTATIN; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DIET; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; CROHN DISEASE; FOOD, FORMULATED; GLUCOCORTICOIDS; HUMANS; PREDNISOLONE; PREDNISONE; RANDOMIZED CONTROLLED TRIALS; TREATMENT FAILURE;

EID: 0030001663     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609004877     Document Type: Article

References (29)

1. Ives CW, Hines C. Crohn's disease. In: Rakel RE, editor. Conn's current therapy. Philadelphia: Saunders, 1994:470-3.
2. Gonzales-Hiux, de Leon R, Fernendez-Banares F, Esteve M, Cabré E, Acero D, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993;34:778-82.
3. Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomised prospective trials comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc 1992;67:328-33.
4. Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Gastroenterology 1991; 101:881-88.
5. Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H, et al. Feasibility and effectiveness of defined-formula diet regimen in treating active Crohn's disease. Scand J Gastroenterol 1990;25:235-44.
6. O'Morain, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ 1984;288:1859-62.
7. Saverymuttu S, Hodgson HJF, Chadwick VS. Controlled trial comparing prednisone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut 1985; 26:994-8.
8. Hunt JB, Payne-James JJ, Palmer Kr. A randomised controlled trial of elemental diet and prednisolone as primary therapy in acute exacerbations of Crohn's disease [abstract]. Gastroenterology 1989;96:A224.
9. Seidman EG, Bouthillier L, Weber AM, Roy CC, Morin CL. Elemental diet versus prednisone as primary treatment of Crohn's disease [abstract]. Gastroenterology 1986;90:1625A.
10. Sanderson JR, Udeen S, Davies PSW, Svage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987;61:123-7.
11. O'Keefe SJD, Ogden J, Rund J, Potter P. Steroids and bowel rest versus elemental diet in the treatment of patients with Crohn's disease: the effects on protein metabolism and immune function. J Parent Ent Nutr 1989;13:455-60.
12. Okada M, Yao T, Yamamoto T, Takenana K, Imamura K, Maeda K, et al. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease. Hepatogastroenterology 1990;37:72-80.
13. Riordan AM, Hunter JO, Cowan JR, Crampton JR, Davidson AR, Dickinson RJ, et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993;342:1131-4.
14. Gorard DA, Hunt, JB, Payne-James JJ, Palmer KP, Rees RGP, Clark ML, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993;34:1198-202.
15. Hervey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;1:514.
16. Sacks HS, Berrier J, Reitman D, Ancona-Bekr VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med 1987;316:450-5.
17. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-48.
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. II. The design and analysis of cohort studies. Lyon: IARC Scientific Publications, 1987:109.
19. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88.
20. Woolf B. On estimating the relation between blood group and disease. Ann Human Genet 1955;9:251-3.
21. Messori A, Rampazzo R. Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputer. Comput Progr Biomed 1993;40:261-7.
22. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.
23. Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Stat Med 1987;6:11-29.
24. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993;269: 2749-53.
25. Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 1986;58:1378-86.
26. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351-5.
27. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985;290:17-25.
28. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as primary treatment of active Crohn's disease. Gastroenterology 1995;108:1056-67.
29. Lau J, Antman EM, Jimenez-Silva J, Kupelink B, Mosteller SF, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.